Taken together, these findings suggest that circulating DKK1 may not serve as a standalone diagnostic marker; nevertheless, its high sensitivity confers a strong negative predictive value, indicating that DKK1 could be a useful adjunct biomarker for screening or ruling out PCOS‐related metabolic morbidities in clinical settings. This evidence concerns the gene DKK1 and polycystic ovary syndrome.